Palifermin and chemotherapy-induced oral mucositis.
作者信息
Palmieri Carlo, Vigushin David
出版信息
N Engl J Med. 2005 Mar 24;352(12):1264-5; author reply 1264-5.
PMID:15791703
Abstract
摘要
相似文献
1
Palifermin and chemotherapy-induced oral mucositis.
N Engl J Med. 2005 Mar 24;352(12):1264-5; author reply 1264-5.
2
Palifermin and chemotherapy-induced oral mucositis.
N Engl J Med. 2005 Mar 24;352(12):1264-5; author reply 1264-5.
3
Palifermin for oral mucositis after intensive therapy for hematologic cancers.
N Engl J Med. 2004 Dec 16;351(25):2590-8. doi: 10.1056/NEJMoa040125.
4
Palifermin and chemotherapy-induced oral mucositis.
N Engl J Med. 2005 Mar 24;352(12):1264-5; author reply 1264-5. doi: 10.1056/NEJM200503243521219.
5
Oral mucositis--the search for a solution.
N Engl J Med. 2004 Dec 16;351(25):2649-51. doi: 10.1056/NEJMe048239.
6
Reduction of radiochemotherapy-induced early oral mucositis by recombinant human keratinocyte growth factor (palifermin): experimental studies in mice.
Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):881-7. doi: 10.1016/j.ijrobp.2005.03.050.
7
Palifermin (Kepivance) for the treatment of oral mucositis in patients with hematologic malignancies requiring hematopoietic stem cell support.
J Oncol Pharm Pract. 2005 Sep;11(3):121-5. doi: 10.1191/1078155205jp159oa.
8
Palifermin (Kepivance) for myelotoxic-therapy-related mucositis.
Med Lett Drugs Ther. 2005 Apr 25;47(1207):36.
9
Cancer therapy-related oral mucositis.
J Dent Educ. 2005 Aug;69(8):919-29.
10
Palifermin: role in the prevention of chemotherapy- and radiation-induced mucositis.
Ann Pharmacother. 2007 Jan;41(1):86-94. doi: 10.1345/aph.1G473. Epub 2006 Dec 26.
Zotero 插件